Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Barrett's esophagus: proton pump inhibitors and chemoprevention II.

Authors
  • And 8 more
Type
Published Article
Journal
Annals of the New York Academy of Sciences
1749-6632
Publisher
Wiley Blackwell (Blackwell Publishing)
Publication Date
Volume
1232
Pages
114–139
Identifiers
DOI: 10.1111/j.1749-6632.2011.06048.x
PMID: 21950810
Source
Medline
License
Unknown

Abstract

The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.

Statistics

Seen <100 times